Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in chronic urticaria (RUSTY)
NCT00216762Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Jan 2006
- Primary completion
- May 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in chronic urticaria (CU), sponsored by Johns Hopkins University. Started Jan 2006; status: terminated.
02
Drugs
rituximab
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on NCT00216762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216762.